In the realm of advanced cancer treatment, biomarker testing is a crucial tool. It helps doctors pick the best targeted therapy for each patient. Yet, many people with advanced cancer do not get this vital testing. This is a big problem. Guidelines suggest that everyone with advanced cancer should
In France, undocumented immigrants face a healthcare system that is far from equal. Two main programs exist: State Medical Aid (SMA) and Urgent and Vital Care (UVC). SMA offers broad healthcare coverage, while UVC is limited to life-threatening situations. This setup raises questions about fairness
Chronic kidney disease (CKD) is a growing health issue worldwide, with a heavy financial burden, especially when it reaches end-stage renal disease (ESRD). ESRD often requires expensive treatments like dialysis or kidney transplants, and costs are expected to rise significantly by 2030. One way to m
Diabetes is becoming more common. It's important to find new ways to help people manage it. This study looks at a special program. It uses mobile health tools and a team of health workers. The goal is to see if this program can help people with diabetes. It also checks if it can save money for the h
Antibiotics are powerful tools in medicine. They help fight infections. But using them too much can lead to resistance. This makes infections harder to treat. Antibiotic Stewardship Programs (ASPs) aim to use these drugs wisely. However, not all ASPs are created equal. Different places use different
Cancer is a tough battle. It's not just about the illness itself. There are hidden costs that come with it. Even in places with universal healthcare, like Europe, patients face big expenses and loss of income. This is what experts call financial toxicity. It's a real problem that needs attention. To
Healthcare systems around the globe are under pressure. Aging populations, complex health needs, and workforce shortages are just a few of the hurdles they face. These issues are pushing up costs and making it hard to provide quality care for everyone. One approach gaining traction is value-based h
The U. S. is looking at a new way to cut down on drug prices. The idea is to match what other rich countries are paying. This is all part of a plan that was announced on a social media platform. The plan is called the “most favored nation” pricing model. It means the U. S. would pay the lowest price
Chest infections can be really serious, causing a lot of health problems and even death. One big issue is when the infection comes back, which can make things much worse for patients and drive up healthcare costs. A recent study dug into why these infections return and what can be done to stop it.
The world of biotech is changing fast, and the US is falling behind. For years, the US has been the go-to place for biotech and pharmaceutical breakthroughs. However, China is rapidly catching up, and it's not because of some secret formula. The US is slowing itself down with too many rules and red
